BIOCRYST PHARMACEUTICA
7.5000
27-十一月-24 16:45:00
15 分钟延时
股票
+0.0100
+0.13%
今日范围
7.4250 - 7.6300
ISIN
N/A
来源
NASDAQ
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 2月 2023 07:00:30 条件 Nasdaq GlobeNewswire
-
03 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
26 1月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
23 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
09 1月 2023 07:05:55 条件 Nasdaq GlobeNewswire
-
09 1月 2023 07:00:40 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 1月 2023 07:00:28 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference
04 1月 2023 07:00:46 条件 Nasdaq GlobeNewswire
-
15 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 12月 2022 16:01:09 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at JMP Securities Hematology & Oncology Summit
05 12月 2022 07:00:26 条件 Nasdaq GlobeNewswire
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health
28 11月 2022 07:00:43 条件 Nasdaq GlobeNewswire
-
10 11月 2022 08:00:21 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
09 11月 2022 07:00:33 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 11月 2022 07:00:46 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones
01 11月 2022 07:00:35 条件 Nasdaq GlobeNewswire
-
24 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst to Report Third Quarter 2022 Financial Results on November 1
18 10月 2022 07:00:39 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 10月 2022 07:00:45 条件 Nasdaq GlobeNewswire
-
14 9月 2022 16:01:10 条件 Nasdaq GlobeNewswire